Chart of the Day: Immunovant (IMVT)
Keep an eye on Immunovant (IMVT). After bouncing from double-bottom support, the stock is now up to $37.50. Helping, JP Morgan just initiated coverage of the stock with an overweight rating, with a price target of $51. The firm believes IMVT could be a key...










